论文信息 - Structure-activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists.

Structure-activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists.

A new series of 2-aminoquinolines has been identified as antagonists of the melanin concentrating hormone receptor (MCH-1R). Syntheses and structure-activity relationships are described leading to a compound having low nanomolar activity against the receptor and demonstrating functional antagonism. Studies also showed that some of the compounds were selective against a range of other G protein-coupled receptors.

[1] Serotonin transporter inhibitors: synthesis and binding potency of 2'-methyl- and 3'-methyl-6-nitroquipazine. , 2000, Bioorganic & medicinal chemistry letters.

[2] B. Lowell,et al. Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[3] Beth Borowsky,et al. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist , 2002, Nature Medicine.

[4] B. Lowell,et al. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. , 2001, The Journal of clinical investigation.

[5] Yuji Ishihara,et al. T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. , 2002, European journal of pharmacology.

[6] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[7] S. Gammeltoft,et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Nature.